OnCore Login

Return to Trial Database

HCRN-GU91-1

A Phase II Study of Altretamine (HEX) for the Treatment of Metastatic Renal Cell Cancer

Status

Study Completed

Cancer Type(s)

Kidney

Study Contact

Publications

A Phase II Study of Altretramine for the Treatment of Metastatic Renal Cell Carcinoma
  • J McClean, P Loehrer, J Picus, R Ansari, E Mitchell, R Reynolds, R Capizzi
Altretamine For the Treatment of Metastatic Renal Cell Carcinoma
  • R Zon, J McClean, D Helman, R Ansari, J Picus, A Sandler, S Williams, P Loehrer

Trial Locations

All sites in which the trial HCRN-GU91-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278